NASDAQ:INVA - Innoviva News Headlines

$11.13
-0.26 (-2.28 %)
(As of 09/18/2019 04:00 PM ET)
Today's Range
$11.11
Now: $11.13
$11.47
50-Day Range
$10.88
MA: $11.41
$11.90
52-Week Range
$10.76
Now: $11.13
$20.54
Volume43,734 shs
Average Volume422,283 shs
Market Capitalization$1.13 billion
P/E Ratio3.17
Dividend YieldN/A
Beta1.51

Headlines

Innoviva (NASDAQ INVA) News Headlines

Source:
DateHeadline
$0.37 EPS Expected for Innoviva Inc (NASDAQ:INVA) This Quarter$0.37 EPS Expected for Innoviva Inc (NASDAQ:INVA) This Quarter
www.americanbankingnews.com - August 31 at 8:13 PM
Innoviva Inc (NASDAQ:INVA) Sees Large Decline in Short InterestInnoviva Inc (NASDAQ:INVA) Sees Large Decline in Short Interest
www.americanbankingnews.com - August 28 at 11:58 PM
Innoviva Enters Oversold Territory - NasdaqInnoviva Enters Oversold Territory - Nasdaq
www.nasdaq.com - August 23 at 6:19 PM
Notable Thursday Option Activity: TWNK, SLB, INVANotable Thursday Option Activity: TWNK, SLB, INVA
www.nasdaq.com - August 8 at 6:47 PM
Innoviva Reports Second Quarter 2019 Financial Results - Business WireInnoviva Reports Second Quarter 2019 Financial Results - Business Wire
www.businesswire.com - July 26 at 7:02 PM
Innoviva EPS misses by $0.09, misses on revenueInnoviva EPS misses by $0.09, misses on revenue
seekingalpha.com - July 25 at 5:25 PM
Innoviva Q2 miss pressures shares, down 12%Innoviva Q2 miss pressures shares, down 12%
seekingalpha.com - July 25 at 5:25 PM
Innoviva Reports Second Quarter 2019 Financial Results - Yahoo FinanceInnoviva Reports Second Quarter 2019 Financial Results - Yahoo Finance
finance.yahoo.com - July 24 at 6:32 PM
Innoviva Reports Second Quarter 2019 Financial ResultsInnoviva Reports Second Quarter 2019 Financial Results
finance.yahoo.com - July 24 at 6:32 PM
Innoviva Becomes OversoldInnoviva Becomes Oversold
www.nasdaq.com - July 23 at 10:50 PM
New 52-Week Low Could Prompt More Insider Buying At INVANew 52-Week Low Could Prompt More Insider Buying At INVA
www.nasdaq.com - July 23 at 10:50 PM
Moleculin Files New Patents for Cancer Candidate Annamycin - Yahoo FinanceMoleculin Files New Patents for Cancer Candidate Annamycin - Yahoo Finance
finance.yahoo.com - July 12 at 9:29 AM
Does The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment? - Yahoo FinanceDoes The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment? - Yahoo Finance
finance.yahoo.com - July 11 at 5:17 PM
Does The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment?Does The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment?
finance.yahoo.com - July 11 at 9:22 AM
Global Trelegy Ellipta (Fluticasone Furoate + Vilanterol + Umeclidinium Bromide) Drug Market Forecast to 2026 - GlobeNewswireGlobal Trelegy Ellipta (Fluticasone Furoate + Vilanterol + Umeclidinium Bromide) Drug Market Forecast to 2026 - GlobeNewswire
www.globenewswire.com - June 29 at 9:24 AM
Breo Ellipta (GlaxoSmithKline/Innoviva) Drug Outlook to 2026: A Combination of Fluticasone Furoate & Vilanterol Indicated for the Treatment of Asthma & COPD - ResearchAndMarkets.com - Yahoo FinanceBreo Ellipta (GlaxoSmithKline/Innoviva) Drug Outlook to 2026: A Combination of Fluticasone Furoate & Vilanterol Indicated for the Treatment of Asthma & COPD - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 24 at 5:25 PM
5 Undervalued Stocks to Buy - Investorplace.com5 Undervalued Stocks to Buy - Investorplace.com
www.investorplace.com - June 20 at 9:22 AM
Celgene (CELG) Hits 52-Week High, Can the Run Continue? - Yahoo FinanceCelgene (CELG) Hits 52-Week High, Can the Run Continue? - Yahoo Finance
finance.yahoo.com - June 18 at 5:47 PM
How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility? - Yahoo FinanceHow Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility? - Yahoo Finance
finance.yahoo.com - June 11 at 10:15 AM
How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility?How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility?
finance.yahoo.com - June 11 at 10:15 AM
Progenity Strengthens Executive Team with the Addition of Eric d’Esparbes as Chief Financial Officer - Yahoo FinanceProgenity Strengthens Executive Team with the Addition of Eric d’Esparbes as Chief Financial Officer - Yahoo Finance
finance.yahoo.com - June 5 at 9:22 AM
You Can Get Buy Signals From Short SellingYou Can Get Buy Signals From Short Selling
investorplace.com - May 22 at 10:45 AM
Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019
www.prnewswire.com - May 21 at 7:20 AM
Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy? - Yahoo FinanceEarnings Estimates Moving Higher for Innoviva (INVA): Time to Buy? - Yahoo Finance
finance.yahoo.com - May 15 at 6:46 PM
Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy?Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy?
finance.yahoo.com - May 15 at 6:46 PM
See what the IHS Markit Score report has to say about Innoviva Inc. - Yahoo FinanceSee what the IHS Markit Score report has to say about Innoviva Inc. - Yahoo Finance
finance.yahoo.com - May 9 at 9:33 AM
Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo FinanceTheravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - May 8 at 9:29 AM
Market Trends Toward New Normal in lululemon athletica inc, Innoviva, aTyr Pharma, and Vivopower International Plc — Emerging Consolidated Expectations, Analyst Ratings - GlobeNewswireMarket Trends Toward New Normal in lululemon athletica inc, Innoviva, aTyr Pharma, and Vivopower International Plc — Emerging Consolidated Expectations, Analyst Ratings - GlobeNewswire
www.globenewswire.com - May 7 at 9:29 AM
Innoviva (INVA), GlaxoSmithKline (GSK) Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint - StreetInsider.comInnoviva (INVA), GlaxoSmithKline (GSK) Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint - StreetInsider.com
www.streetinsider.com - May 2 at 6:35 PM
Innoviva Reports First Quarter 2019 Financial Results - Yahoo FinanceInnoviva Reports First Quarter 2019 Financial Results - Yahoo Finance
finance.yahoo.com - May 1 at 6:20 PM
Innoviva Reports First Quarter 2019 Financial ResultsInnoviva Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 1 at 6:20 PM
Is Innoviva, Inc. (INVA) A Good Stock To Buy? - Yahoo FinanceIs Innoviva, Inc. (INVA) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - April 30 at 5:57 PM
Is Innoviva, Inc. (INVA) A Good Stock To Buy?Is Innoviva, Inc. (INVA) A Good Stock To Buy?
finance.yahoo.com - April 30 at 5:57 PM
Commit To Buy Innoviva At $10, Earn 9.9% Annualized Using Options - NasdaqCommit To Buy Innoviva At $10, Earn 9.9% Annualized Using Options - Nasdaq
www.nasdaq.com - April 26 at 6:02 PM
Those Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It - Yahoo FinanceThose Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It - Yahoo Finance
finance.yahoo.com - April 24 at 5:34 PM
Those Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For ItThose Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It
finance.yahoo.com - April 24 at 5:34 PM
Innoviva Becomes Oversold (INVA)Innoviva Becomes Oversold (INVA)
www.nasdaq.com - April 18 at 6:26 PM
Innoviva, Inc.: Not As Cheap As It Looks - Seeking AlphaInnoviva, Inc.: Not As Cheap As It Looks - Seeking Alpha
seekingalpha.com - April 10 at 11:30 AM
3 Top Biotech Stocks to Buy in April - Motley Fool3 Top Biotech Stocks to Buy in April - Motley Fool
www.fool.com - April 8 at 12:02 PM
Innoviva, Inc. Estimate MomentumInnoviva, Inc. Estimate Momentum
www.nasdaq.com - March 21 at 7:24 AM
Innoviva IncInnoviva Inc
www.bloomberg.com - March 19 at 9:51 AM
A Dozen 13D DealsA Dozen 13D Deals
finance.yahoo.com - March 9 at 9:33 AM
How Many Insiders Bought Innoviva, Inc. (NASDAQ:INVA) Shares?How Many Insiders Bought Innoviva, Inc. (NASDAQ:INVA) Shares?
finance.yahoo.com - March 8 at 6:28 PM
Innoviva (INVA) Shares Cross Below 200 DMAInnoviva (INVA) Shares Cross Below 200 DMA
www.nasdaq.com - March 1 at 5:41 PM
Monday 2/25 Insider Buying Report: INVA, HCAPMonday 2/25 Insider Buying Report: INVA, HCAP
www.nasdaq.com - February 25 at 6:06 PM
Innoviva Inc (INVA) Files 10-K for the Fiscal Year Ended on December 31, 2018Innoviva Inc (INVA) Files 10-K for the Fiscal Year Ended on December 31, 2018
finance.yahoo.com - February 19 at 5:56 PM
Innoviva: 4Q Earnings SnapshotInnoviva: 4Q Earnings Snapshot
finance.yahoo.com - February 7 at 9:33 AM
INVA Makes Notable Cross Below Critical Moving AverageINVA Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - February 6 at 5:34 PM
RSI Alert: Innoviva (INVA) Now OversoldRSI Alert: Innoviva (INVA) Now Oversold
www.nasdaq.com - February 6 at 5:34 PM
Innoviva Reports Fourth Quarter 2018 Financial ResultsInnoviva Reports Fourth Quarter 2018 Financial Results
finance.yahoo.com - February 6 at 5:34 PM
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel